Risk factors for late smear and culture conversion in tuberculosis patients Source: Annual Congress 2010 - Prognosis of tuberculosis Year: 2010
Stage IV sarcoidosis: comparison of survival with the general population and causes of death Source: Eur Respir J 2011; 38: 1368-1373 Year: 2011
Factors affecting sputum conversion time in patients with smear positive tuberculosis Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control Year: 2007
COPD assessment: I, II, III, IV and/or A, B, C, D Source: Eur Respir J 2014; 43: 949-950 Year: 2014
Collagen I, III and IV content in airways and lung parenchyma of COPD patients Source: Annual Congress 2010 - Proteases and the matrix Year: 2010
Comparison the frequency of human T-lymphocyte type 1 (HTLV 1) infection in tuberculosis patients with control group without tuberculosis Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011
The influence of roflumilast on the IV-type collagen level in patients with III stage COPD Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012
Changes in bronchial mucous membrane depending on the stage of COPD (I, II) Source: Annual Congress 2011 - COPD mechanisms Year: 2011
Frequency of class I and II HLA alleles in patients with lung cancer according to responses of chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 329s Year: 2005
Polymorphisms in the type IV collagen alpha3 gene and the risk of COPD Source: Eur Respir J 2008; 32: 35-41 Year: 2008
Physician-diagnosed COPD GOLD stage IV in Östersund, Sweden: prevalence and patient characteristics Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006
Predictors of delayed sputum culture conversion in tuberculosis patients Source: Annual Congress 2011 - Clinical tuberculosis Year: 2011
To determine the acquired resistance of mycobacterium tuberculosis by culture to 1st line anti-tuberculous drugs in non responding smear positive patients who have taken category 1 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Heterogeneity of stage III and its implication on treatment Source: European Multidisciplinary Conference in Thoracic Oncology 2009 Year: 2009
Development of multi-drug resistant tuberculosis among patients treated with category II regimen: A lung center of the Philippines experience Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II Year: 2012
The outcome of tuberculosis cases who still smear positive at the end of extended initial phase Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis Year: 2008
Factors associated with sputum culture conversion in patients with pulmonary tuberculosis Source: International Congress 2017 – TB: co-morbidities and outcome Year: 2017
The analysis of factors associated with duration of the diagnostic period at patients of lungs tuberculosis Source: Annual Congress 2009 - Clinical tuberculosis Year: 2009
Outcome of shorter treatment after culture conversion in non-cavitary MAC lung disease Source: International Congress 2019 – Clinical and translational studies of bronchiectasis and non-TB mycobacterial infection Year: 2019
Pattern of drug resistance among patients who fail Cat II regimen and patients who fail standard treatment: is there any difference? Source: Eur Respir J 2006; 28: Suppl. 50, 378s Year: 2006